Procter & Gamble Co (PG)

PG (NYSE:Consumer Non-Durables) EQUITY
$89.75
pos +1.52
+1.72%
Today's Range: 88.29 - 90.22 | PG Avg Daily Volume: 16,842,900
Last Update: 09/30/16 - 4:01 PM EDT
Volume: 123,658,743
YTD Performance: 13.02%
Open: $88.30
Previous Close: $88.23
52 Week Range: $71.29 - $89.73
Oustanding Shares: 2,668,751,125
Market Cap: 235,463,911,759
6-Month Chart
TheStreet Ratings Grade for PG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 1 1 1 1
Hold 4 4 5 6
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.00 2.00 2.06 2.11
Latest Dividend: 0.67
Latest Dividend Yield: 3.04%
Dividend Ex-Date: 07/20/16
Price Earnings Ratio: 25.28
Price Earnings Comparisons:
PG Sector Avg. S&P 500
25.28 27.70 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.00% 24.76% 18.73%
GROWTH 12 Mo 3 Yr CAGR
Revenue -8.20 -0.10 -0.03
Net Income -39.40 0.00 -0.01
EPS -40.10 -0.30 -0.13
Earnings for PG:
EBITDA 16.95B
Revenue 76.28B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (06/17) FY (06/18)
Average Estimate $0.98 $1.08 $3.88 $4.20
Number of Analysts 10 9 13 10
High Estimate $1.01 $1.10 $3.95 $4.26
Low Estimate $0.95 $1.04 $3.85 $4.13
Prior Year $0.98 $1.04 $3.67 $3.88
Growth Rate (Year over Year) -0.10% 3.74% 5.81% 8.19%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Owning a couple of my new on-the-fly acronym looks smart.
A stronger dollar and an active secondary market in used equipment should already be priced into the stock.
A stronger dollar and an active secondary market in used equipment should already be priced into the stock.
The stock has gotten off to a rousing start, but competition in the cosmetics space should cause investors to look below the surface.
Without it, the uncertainty would be incredible between now and November.
But if you got in McDonald's late, fears about Q3 are still elevated.
The leadership is quite stark.
The failed trial is among the biggest single blows by a major pharma player.
Walmart's move demonstrates that you have to feed the beast or risk getting eaten.

Columnist Conversations

On Wednesday of last week NFLX appeared headed for a deep breakdown.  The stock fell over 3.4% that day o...
We added this one Monday and mentioned it Tuesday right here in CC, we'll take it off the board. SOLD WDC O...
The market is rebounding nicely after yesteday's sell-off.  Biotech has recaptured half of its three perc...
The Federal Reserve has made it relatively clear that they intend to raise interest rates in the December mee...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.